Diagram of semaglutide activating a key receptor called GLP-1
Juan Gartner/Science Photo Library/Alamy
Animal studies have shown that the active ingredient in Ozempic and Wigovy, a drug called semaglutide, may have direct beneficial effects on the heart within a few weeks, in addition to the long-term benefits of weight loss. It was done.
The findings suggest that heart disease patients who do not have type 2 diabetes or obesity, which semaglutide is primarily used to treat, may also benefit from taking this type of drug. “We may be missing out on a lot of people who could potentially benefit,” said Christopher Stone of Brown University.
(Tag Translate) Pharmaceuticals
